- Home
- UOKA vs NDRA Comparison
UOKA vs NDRA Comparison
Compare UOKA & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UOKA
- NDRA
- Stock Information
- Founded
- UOKA 2002
- NDRA 2007
- Country
- UOKA United Kingdom
- NDRA United States
- Employees
- UOKA N/A
- NDRA N/A
- Industry
- UOKA
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- UOKA
- NDRA Health Care
- Exchange
- UOKA NYSE
- NDRA Nasdaq
- Market Cap
- UOKA 2.7M
- NDRA 2.3M
- IPO Year
- UOKA N/A
- NDRA 2017
- Fundamental
- Price
- UOKA $2.78
- NDRA $6.35
- Analyst Decision
- UOKA
- NDRA Strong Buy
- Analyst Count
- UOKA 0
- NDRA 1
- Target Price
- UOKA N/A
- NDRA $46.00
- AVG Volume (30 Days)
- UOKA 58.6K
- NDRA 5.0M
- Earning Date
- UOKA 08-16-2025
- NDRA 08-13-2025
- Dividend Yield
- UOKA N/A
- NDRA N/A
- EPS Growth
- UOKA N/A
- NDRA N/A
- EPS
- UOKA N/A
- NDRA N/A
- Revenue
- UOKA $48,375.00
- NDRA N/A
- Revenue This Year
- UOKA N/A
- NDRA N/A
- Revenue Next Year
- UOKA N/A
- NDRA N/A
- P/E Ratio
- UOKA N/A
- NDRA N/A
- Revenue Growth
- UOKA N/A
- NDRA N/A
- 52 Week Low
- UOKA $1.98
- NDRA $2.90
- 52 Week High
- UOKA $42.50
- NDRA $168.00
- Technical
- Relative Strength Index (RSI)
- UOKA N/A
- NDRA 54.22
- Support Level
- UOKA N/A
- NDRA $6.18
- Resistance Level
- UOKA N/A
- NDRA $7.34
- Average True Range (ATR)
- UOKA 0.00
- NDRA 0.81
- MACD
- UOKA 0.00
- NDRA -0.18
- Stochastic Oscillator
- UOKA 0.00
- NDRA 5.12
About UOKA MDJM LTD
MDJM Ltd is engaged in providing real estate agency services to its real estate developer clients, and provides, on an as-needed basis, real estate consulting services and independent training services. The company generates all of its revenue from Hotel income. The company derives a majority of its revenue from the United Kingdom.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.